Abstract
Wearable technologies are envisaged to provide critical support to future healthcare systems. Hearables - devices worn in the ear - are of particular interest due to their ability to provide health monitoring in an efficient, reliable and unobtrusive way. Despite the considerable potential of these devices, the ECG signal that can be acquired through a hearable device worn on a single ear is still relatively unexplored. Biophysics modelling of ECG volume conduction was used to establish principles behind the single ear ECG signal, and measurements of cardiac rhythms from 10 subjects were found to be in good correspondence with simulated equivalents. Additionally, the viability of the single ear ECG in real-world environments was determined through one hour duration measurements during a simulated driving task on 5 subjects. Results demonstrated that the single ear ECG resembles the Lead I signal, the most widely used ECG signal in the identification of heart conditions such as myocardial infarction and atrial fibrillation, and was robust against real-world measurement noise, even after prolonged measurements. This study conclusively demonstrates that hearables can enable continuous monitoring of vital signs in an unobtrusive and seamless way, with the potential for reliable identification and management of heart conditions such as myocardial infarction and atrial fibrillation.
Introduction
As healthcare moves toward continuous, remote monitoring, wearable devices have become essential tools. While smartwatches and chest straps are currently the most common platforms for heart monitoring, they possess inherent limitations. Smartwatches primarily rely on photoplethysmography (PPG), which tracks blood volume changes rather than the heart's electrical activity, limiting its diagnostic utility for complex arrhythmias. Conversely, chest straps provide high-quality electrocardiogram (ECG) data but are often considered too obtrusive for long-term, daily use.
"Hearables"—wearable devices situated in the ear—offer a compelling alternative. The ear provides a stable, discrete platform for electronics. However, recording an ECG from a single ear is technically challenging because the electrical potential difference across the small distance of the ear canal or pinna is minute. This study investigates the biophysical feasibility and practical application of single-ear ECG monitoring.
Methodology
The researchers employed a dual-method approach combining computational modeling with human subject validation.
Biophysical Modeling
To understand the theoretical propagation of cardiac signals, the team used a "forward modeling" approach. They applied Maxwell’s equations to a 3D dielectric model of the human body, specifically the VHP-Female Computational Phantom. This allowed for the simulation of how electrical potentials from the heart travel through various tissues to reach the head and ears.
Empirical Validation
Two distinct experiments were conducted to validate the model:
- Mapping Experiment: ECG signals were recorded from 10 healthy subjects at rest. Electrodes were placed at multiple points, including the scalp, ear (helix and concha), and neck, to map the potential gradient across the head.
- Real-World Feasibility: To test robustness against noise, 5 subjects wore sensors for one hour during a simulated driving task. This introduced common artifacts such as muscle activity (EMG) and movement.
Signal Processing
Due to the low signal-to-noise ratio (SNR) of ear-based recordings, the team utilized median averaging over multiple cardiac cycles (ranging from 2 to 540 cycles). A reference wrist-ECG was used to time the R-peaks for accurate averaging.
Key Results
Lead I Correspondence
A primary finding is that the single-ear ECG signal serves as a similar projection plane to the standard Lead I ECG (measured between the left and right arms). The single-ear ECG showed a high Pearson correlation coefficient of 0.85 to 0.86 with the standard Lead I signal, which is critical for identifying conditions like atrial fibrillation.
Waveform Fidelity and Timing
Both simulations and physical measurements confirmed a significant potential drop as one moves from the base of the neck toward the scalp. While the ear signal is faint (approximately 0.001 mV), it retains the characteristic timing and shape of a standard ECG. The timing error for key cardiac waves (P, Q, S, T) relative to the R-peak was approximately 7–10 ms for the ear, demonstrating high temporal accuracy.
Robustness in Real-World Scenarios
During the driving simulation, the single-ear channel successfully captured cardiac rhythms despite the presence of noise. While the signal required more averaging compared to cross-ear measurements, averaging approximately 240 cycles (3-4 minutes of data) produced a high-fidelity waveform suitable for clinical analysis.
Discussion and Conclusion
This study demonstrates that single-ear ECG recording is not only theoretically possible but practically feasible for continuous monitoring. The close resemblance to Lead I signals suggests that hearables could eventually be used to detect myocardial infarction and manage arrhythmias unobtrusively.
However, limitations remain. The extremely low SNR requires sophisticated bio-amplifiers and signal averaging, which currently limits "beat-by-beat" analysis in noisy environments. Future research will focus on "self-referencing" methods—potentially using collocated MEMS sensors to detect mechanical heart activity—to eliminate the need for an external reference device. Testing on diverse patient populations with known cardiac pathologies will be the next step in bringing this technology to clinical practice.
Summary updated